Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Corsair Gaming Inc (CRSR) vs 10X Genomics Inc (TXG) Price & Performance

Corsair Gaming IncTrade
10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Corsair Gaming Inc vs 10X Genomics Inc — how do they compare? Corsair Gaming Inc trades at $12.95 (market cap $1.39B), while 10X Genomics Inc trades at $57.12 (market cap $7.61B). The key difference: 10X Genomics Inc is far larger — about 5.5× Corsair Gaming Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Corsair Gaming Inc nearer its low. Which is the better fit depends on your goals.

CRSRTXG
Market Cap
$1.39B$7.61B
Sector
TechnologyHealth
52-Week High
$14.35$58.57
52-Week Low
$4.58$11.34
Enterprise Value
$1.38B$7.14B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Corsair Gaming Inc

Corsair Gaming (CRSR) trades at $12.96, down 5.47% today, but maintains a bullish technical signal with strong moving average support. Recent Q2 2026 earnings beat expectations with EPS of $0.23 versus $0.07 expected, and the company raised full-year guidance. Revenue for 2025 was $1.47 billion, though net income was negative $16.16 million, reflecting a net margin of -1.1%. The stock's valuation shows a P/E of 41.39 and P/S of 0.95, with analyst consensus leaning toward Hold but with a $12.40 price target slightly below current levels.

The outlook for CRSR is mixed; strong earnings beats and raised guidance signal operational improvement, but profitability remains a challenge with inconsistent net income. Key risks include competitive pressures in gaming hardware and reliance on consumer spending cycles. Upside potential hinges on sustained margin expansion and successful integration of recent acquisitions like Trak Racer.

10X Genomics Inc

TXG (10x Genomics) trades at $56.95, down 2.77% on the day. The stock exhibits bullish technical signals with strong moving averages, though RSI levels suggest overbought conditions. Fundamentally, the company shows improving trends with Q2 2026 earnings beating estimates and a narrowing net loss margin from -41.23% in 2023 to -12.18% in 2026. Recent news highlights collaborations with Cleveland Clinic and acquisition of Proteintech Genomics, expanding multiomics capabilities.

Outlook: Growth potential exists through market expansion and innovation, but risks include persistent unprofitability and high valuation multiples. Analyst sentiment is mixed with a $46 consensus target below current price, indicating caution despite recent operational improvements.

Returns comparison

Trailing returns across standard periods

About Corsair Gaming Inc

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment

Read more on CRSR

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG